Prediction of lung cancer histological types by RT-qPCR gene expression in FFPE specimens.

[1]  Christopher R. Cabanski,et al.  Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets. , 2013, Archives of pathology & laboratory medicine.

[2]  D. Kuik,et al.  Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma , 2012, Virchows Archiv.

[3]  Mark T. W. Ebbert,et al.  PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers , 2012, BMC Medical Genomics.

[4]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[5]  Iver Petersen,et al.  Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study , 2012, Modern Pathology.

[6]  Matthew D. Wilkerson,et al.  Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation , 2012, PloS one.

[7]  A. Olshan,et al.  High XRCC1 Protein Expression Is Associated with Poorer Survival in Patients with Head and Neck Squamous Cell Carcinoma , 2011, Clinical Cancer Research.

[8]  H. Asamura,et al.  Utility of 10 Immunohistochemical Markers Including Novel Markers (Desmocollin-3, Glypican 3, S100A2, S100A7, and Sox-2) for Differential Diagnosis of Squamous Cell Carcinoma from Adenocarcinoma of the Lung , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[11]  Jonathan W. Pillow,et al.  POSTER PRESENTATION Open Access , 2013 .

[12]  Christopher R. Cabanski,et al.  Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types , 2010, Clinical Cancer Research.

[13]  Jae K. Lee,et al.  Statistical Bioinformatics: A Guide for Life and Biomedical Science Researchers , 2010 .

[14]  A. Nobel,et al.  Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Rainer Haas,et al.  Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers , 2008, Journal of Translational Medicine.

[16]  S. Lippman,et al.  Lung cancer. , 2008, The New England journal of medicine.

[17]  Igor Jurisica,et al.  Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study , 2008, Nature Medicine.

[18]  Johan Vansteenkiste,et al.  Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Charles M Perou,et al.  Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues. , 2007, Clinical chemistry.

[20]  Stefano Monti,et al.  Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Alan R. Dabney.  ClaNC: point-and-click software for classifying microarrays to nearest centroids , 2006, Bioinform..

[22]  L. Chin,et al.  High-resolution genomic profiles of human lung cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[24]  Charles M Perou,et al.  Statistical modeling for selecting housekeeper genes , 2004, Genome Biology.

[25]  David M Jablons,et al.  Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Charles A Powell,et al.  Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. , 2003, The American journal of pathology.

[27]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[28]  Carl Virtanen,et al.  Integrated classification of lung tumors and cell lines by expression profiling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  David E. Misek,et al.  Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.

[30]  D. Botstein,et al.  Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  E. Lander,et al.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[33]  A. J. Robertson,et al.  Observer variability in histopathological reporting of non-small cell lung carcinoma on bronchial biopsy specimens. , 1996, Journal of clinical pathology.

[34]  A. J. Robertson,et al.  Observer variability in histopathological reporting of malignant bronchial biopsy specimens. , 1994, Journal of clinical pathology.

[35]  H. Hansen,et al.  Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.

[36]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.